Attached files
| file | filename |
|---|---|
| 10-Q - URIGEN PHARMACEUTICALS, INC FORM 10-Q - Urigen Pharmaceuticals, Inc. | form10q.htm |
| EX-31.1 - EXHIBIT 31.1 - Urigen Pharmaceuticals, Inc. | ex311.htm |
Exhibit 32.1
CERTIFICATION PURSUANT TO 18 U.S.C.
SECTION 1350 AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF
2002
Pursuant
to 18 U.S.C. § 1350, as created by Section 906 of the Sarbanes-Oxley Act of
2002, the undersigned officer of Urigen Pharmaceuticals, Inc. (the
“Company”) hereby certifies, to such officer’s knowledge, that:
|
(i)
|
the
accompanying quarterly report on Form 10-Q of the Company for the
fiscal quarter ended December 31, 2009 (the “Report”) fully complies with
the requirements of Section 13(a) or Section 15(d), as
applicable, of the Securities Exchange Act of 1934, as amended;
and
|
|
|
(ii)
|
the
information contained in the Report fairly presents, in all material
respects, the financial condition and results of operations of the
Company.
|
|
Date:
February 16, 2010
|
/s/
William J. Garner, MD
|
||
|
WILLIAM
J. GARNER, MD
|
|||
|
President
and Chief Executive Officer
|
|||
|
(Principal
Executive Officer and Principal Financial and Accounting
Officer)
|